Pheno and UCB reveal neurodegenerative disease programme agreement
Global preclinical programme has the potential for disease modifying therapeutics
Read More
Tag: neurodegenrative
Research provides hope for patients with neurodegenerative disease
Findings highlight a potential new drug candidate that may delay disease progression
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
